| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |